Mikiya Miyazato Selected Research

C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)

9/2018	C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
1/2018	Adipocyte-specific expression of C-type natriuretic peptide suppresses lipid metabolism and adipocyte hypertrophy in adipose tissues in mice fed high-fat diet.
1/2017	Myeloprotective effects of C-type natriuretic peptide on cisplatin-induced bone marrow granulocytopenia in mice.
1/2017	Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced Obesity.
9/2016	Erratum to: C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.
2/2016	C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.
1/2016	C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells.
4/2015	C-type natriuretic peptide attenuates lipopolysaccharide-induced acute lung injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikiya Miyazato Research Topics

Disease

10	Heart Failure 01/2022 - 01/2012
10	Obesity 01/2020 - 01/2012
9	Neoplasms (Cancer) 01/2022 - 01/2015
8	Myocardial Infarction 01/2019 - 01/2012
7	Cardiac Arrhythmias (Arrythmia) 06/2021 - 01/2012
5	Congenital Heart Defects (Congenital Heart Defect) 01/2022 - 01/2018
5	Inflammation (Inflammations) 01/2020 - 03/2015
4	Fibrosis (Cirrhosis) 01/2020 - 10/2013
4	Hypoxia (Hypoxemia) 01/2019 - 01/2014
4	Insulin Resistance 09/2018 - 08/2015
4	Neoplasm Metastasis (Metastasis) 01/2018 - 03/2015
4	Body Weight (Weight, Body) 01/2018 - 05/2008
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017 - 10/2015
3	Cardiomegaly (Heart Hypertrophy) 01/2020 - 05/2008
3	Ischemia 01/2018 - 10/2009
3	Acute Lung Injury 01/2018 - 10/2014
3	AIDS-Related Complex (ARC) 11/2010 - 10/2005
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020 - 01/2020
2	Pulmonary Hypertension 01/2019 - 01/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 01/2014
2	Alcoholic Fatty Liver 09/2018 - 01/2018
2	Infarction (Infarctions) 01/2018 - 10/2013
2	Brain Injuries (Brain Injury) 01/2018 - 04/2015
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2018 - 04/2015
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2018
2	Dehydration (Water Stress) 01/2017 - 01/2011
2	Agranulocytosis (Granulocytopenia) 01/2017 - 01/2016
2	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2016 - 10/2015
2	Lung Neoplasms (Lung Cancer) 02/2016 - 03/2015
2	Stroke (Strokes) 04/2015 - 05/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 01/2012
2	Starvation 07/2007 - 08/2005
1	Hypotension (Low Blood Pressure) 01/2022
1	Bradycardia 06/2021
1	Tachycardia (Tachyarrhythmias) 06/2021
1	Pathologic Processes 12/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020
1	Left Ventricular Dysfunction 01/2020
1	Heart Diseases (Heart Disease) 01/2019
1	Liver Diseases (Liver Disease) 09/2018
1	Dyslipidemias (Dyslipidemia) 09/2018
1	Neuroblastoma 01/2018
1	Intellectual Disability (Idiocy) 01/2018
1	Premature Birth (Birth, Premature) 01/2018

Drug/Important Bio-Agent (IBA)

14	Atrial Natriuretic Factor (ANF)IBA 01/2022 - 10/2009
10	GhrelinIBA 01/2019 - 08/2005
9	Natriuretic PeptidesIBA 01/2022 - 05/2008
9	Messenger RNA (mRNA)IBA 01/2018 - 10/2005
8	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 09/2018 - 04/2015
6	Peptides (Polypeptides)IBA 01/2020 - 10/2005
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 12/2014
6	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2015
5	Hormones (Hormone)IBA 01/2019 - 10/2005
5	LipopolysaccharidesIBA 01/2018 - 10/2014
3	atrial natriuretic factor receptor AIBA 01/2022 - 05/2008
3	Ghrelin ReceptorsIBA 01/2017 - 01/2011
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017 - 10/2015
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 11/2010 - 10/2005
2	neuromedin UIBA 01/2020 - 01/2018
2	CytokinesIBA 01/2019 - 02/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 02/2016
2	LipidsIBA 09/2018 - 01/2018
2	Insulin (Novolin)FDA Link 09/2018 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2018 - 01/2018
2	NeuropeptidesIBA 01/2018 - 10/2011
2	E-SelectinIBA 01/2018 - 03/2015
2	salicylhydroxamic acid (SHAM)IBA 01/2018 - 06/2014
2	Pharmaceutical PreparationsIBA 04/2015 - 08/2014
2	hexarelinIBA 06/2014 - 10/2013
1	urotensin IIIBA 12/2020
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2020
1	neuromedin U receptorIBA 01/2020
1	AldosteroneIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	CD40 Ligand (CD40L)IBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	MonocrotalineIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Vascular Endothelial Growth Factor DIBA 01/2019
1	Fas Ligand Protein (Fas Ligand)IBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 09/2018
1	CholesterolIBA 09/2018
1	Choline (Choline Chloride)IBA 09/2018
1	CDAA (Randox)IBA 09/2018
1	AcidsIBA 09/2018
1	asparagine-oxo-acid aminotransferaseIBA 09/2018
1	Triglycerides (Triacylglycerol)IBA 09/2018
1	Valsartan (Vals)FDA Link 01/2018
1	Interleukin-15 (Interleukin 15)IBA 01/2018

Therapy/Procedure

4	Therapeutics 06/2021 - 01/2012
4	Ligation 06/2014 - 01/2012
2	Transplantation 10/2013 - 09/2012
1	Fetal Therapies (Fetal Therapy) 06/2021
1	Glycemic Control 09/2018
1	Drug Therapy (Chemotherapy) 01/2018